FRUMENTO, GIULIA
 Distribuzione geografica
Continente #
EU - Europa 528
Totale 528
Nazione #
IT - Italia 528
Totale 528
Città #
Genova 171
Genoa 147
Rapallo 108
Vado Ligure 97
Bordighera 5
Totale 528
Nome #
A2A-D2 heteromers on striatal astrocytes: Biochemical and biophysical evidence 160
Acute stress induces short- and long-lasting modifications of glutamate transmission in the prefrontal cortex at pre- and peri-synaptic compartments 71
Nearly 30 years of animal models to study amyotrophic lateral sclerosis: A historical overview and future perspectives. 53
Changes at glutamate tripartite synapses in the prefrontal cortex of a new animal model of resilience/vulnerability to acute stress 48
Acute Ketamine Facilitates Fear Memory Extinction in a Rat Model of PTSD Along With Restoring Glutamatergic Alterations and Dendritic Atrophy in the Prefrontal Cortex 47
Blocking glutamate mGlu5 receptors with the negative allosteric modulator CTEP improves disease course in SOD1G93A mouse model of amyotrophic lateral sclerosis 46
In-vitro and in-vivo studies depict metabotropic glutamate receptor 5 as a potential pharmacological target to modulate disease progression in ALS 46
A repurposing approach to improve disease outcome in SOD1G93A mice by counteracting oligodendrocyte dysfunction and neuroinflammation 13
Montelukast improves disease outcome in SOD1G93A female mice by counteracting oligodendrocyte dysfunction and aberrant glial reactivity 13
Montelukast improves disease progression in the female SOD1G93A mouse model of ALS by restoring oligodendrocyte maturation and counteracting altered glial reactivity 11
A repurposing approach to delay disease progression in SOD1G93A mice by counteracting oligodendrocyte dysfunction 10
Acute Ketamine Facilitates Fear Memory Extinction in a Rat Model of PTSD Along With Restoring Glutamatergic Alterations and Dendritic Atrophy in the Prefrontal Cortex. 10
Pharmacological blockade of the P2Y-like GPR17 receptor with montelukast delays disease progression by counteracting oligodendrocyte dysfunction in the SOD1G93A mouse model of amyotrophic lateral sclerosis 9
Montelukast improves disease outcomes in SOD1G93A female mice by counteracting oligodendrocyte dysfunction and aberrant glial reactivity 8
Effects of the in-vivo treatment with the non-selective GPR17 antagonist montelukast on disease outcome in the SOD1G93A mouse model of ALS 7
In-vivo treatment with the GPR17 antagonist montelukast improves lifespan and delays disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis 5
null 1
Totale 558
Categoria #
all - tutte 2.945
article - articoli 1.756
book - libri 0
conference - conferenze 877
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.578


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202043 0 0 0 0 6 8 9 6 4 6 2 2
2020/202135 1 2 0 2 0 0 0 2 1 21 3 3
2021/202288 3 2 7 0 4 1 11 26 7 9 7 11
2022/2023131 12 12 4 15 14 20 0 4 26 8 15 1
2023/2024130 3 7 7 10 18 41 14 6 4 3 9 8
2024/2025114 18 21 8 27 40 0 0 0 0 0 0 0
Totale 558